What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never recover their health, even with antiretroviral treatment?

Dr. Madeleine Durand and Andrés Finzi, researchers at the CRCHUM, Université de Montréal’s affiliated hospital research centre, will explore this through the launch of a groundbreaking clinical trial this fall.

For children with severe lung diseases, transplantation can be the last hope for survival, yet its practice has remained extremely rare worldwide. 

Three graduate students in CSHL’s dos Santos lab have developed a tool called MaGNet to quickly measure changes in mouse mammary glands. This open-source technology can be used to study how hormonal changes affect mammary glands and may one day allow for earlier breast cancer diagnoses.

• Most patients receiving chemotherapy with taxanes or platinum salts develop painful neuropathy in hands and feet, often forcing dose reduction or treatment interruption.

• Published in Clinical and Translational Oncology, the study demonstrates that topical application of Oncapsisens® delays and reduces neuropathic symptoms, paving the way for new preventive options for cancer patients.

A new study from researchers at Intermountain Health in Salt Lake City finds that a comprehensive program with a strong focus on education in the health system’s urgent care clinics and emergency departments significantly increased HIV testing for patients being evaluated for other sexually transmitted diseases, helping to increase the number of previously undiagnosed patients who learned they were living with HIV and promptly connected to care.